BIOMAT Database Logo BIOMAT Database Logo

Multi-drug resistance pattern of bacterial isolates from urinary tract infection. 2023

- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Department of Microbiology, Peshawar Medical College, Peshawar, Pakistan.

In the community and among hospitalized patients, urinary tract infections (UTIs) rank as the most common bacterial infections. The researchers processed urine samples obtained from affiliated hospitals of Peshawar Medical College. The samples were examined under a microscope to assess the presence of bacteria, pus cells and red blood cells. Following this, the samples were inoculated on MacConkey and blood agar and subsequent antibiotic susceptibility testing was conducted. The findings revealed that 35.9% of hospitalized patients and 16.9% of outpatients were diagnosed with UTIs. Furthermore, 82.2% of the identified UTIs were found to be multidrug-resistant (MDR), with MDR Escherichia coli accounting for 77% of cases. Trimethoprim sulfamethazine (26.8%), penicillin (0%), cefepime (27.8%), cefotaxime (23.7%), aztreonam (2.1%), meropenem (86.6%), ciprofloxacin (51.5%), amoxicillin/clavulanic acid (37.1%), nitrofurantoin (70.1%), gentamycin (73%), ceftazidime (19.5%), levofloxacin (51.5%) and ceftriaxone (25.77%) were subjected to antibiotic susceptibility testing. It is concerning that among the 13 antibiotics examined, solely nitrofurantoin displayed oral efficacy as an effective treatment choice for UTIs.

UI MeSH Term Description Entries
D009582 Nitrofurantoin A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. Furadantin,Furadantine,Furadoine,Furadonine,Furantoin,Macrodantin,Nitrofurantoin Sodium Salt,Nitrofurantoin, Monohydrate
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077723 Cefepime A fourth-generation cephalosporin antibacterial agent that is used in the treatment of infections, including those of the abdomen, urinary tract, respiratory tract, and skin. It is effective against PSEUDOMONAS AERUGINOSA and may also be used in the empiric treatment of FEBRILE NEUTROPENIA. Axépim,BMY 28142,BMY-28142,Cefepim,Cefepime Hydrochloride,Maxipime,Quadrocef,BMY28142
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001398 Aztreonam A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. Az-threonam,Azactam,Azthreonam,SQ-26,776,Urobactam,Az threonam,SQ 26,776,SQ26,776
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Multi-drug resistance of Escherichia coli from the urinary tract.
March 2003, Saudi medical journal,
- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Catheter-Associated Urinary Tract Infection: Incidence, Associated Factors and Drug Resistance Patterns of Bacterial Isolates in Southern Ethiopia.
January 2021, Infection and drug resistance,
- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients.
May 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Antibiotic resistance pattern of urinary tract isolates of Escherichia coli from Kumaun region.
March 2010, The Journal of communicable diseases,
- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Nosocomial infection of the urinary tract: pattern of antibiotic use and drug resistance.
March 1997, East African medical journal,
- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Increasing incidence of bacterial, resistance to antibiotics by isolates from the urinary tract.
December 2005, Nigerian journal of clinical practice,
- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan.
January 2000, The American journal of tropical medicine and hygiene,
- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Etiology and antimicrobial susceptibility pattern of bacterial pathogens from urinary tract infection.
June 2012, Nepal Medical College journal : NMCJ,
- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection.
June 1995, The Journal of infectious diseases,
- Faiza Asghar, and - Sardar Muhammad, and - Aftab Ahmad Anjum, and - Tehreem Ali, and - Abdul Shaheed Asghar, and - Sobia Naureen, and - Rabia Manzoor
Emerging Antibiotic Resistance to Bacterial Isolates from Human Urinary Tract Infections in Grenada.
September 2019, Cureus,
Copied contents to your clipboard!